BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19734449)

  • 41. [Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation].
    Weniger MA; Melzner I; Menz CK; Wegener S; Bucur AJ; Dorsch K; Mattfeldt T; Barth TF; Möller P
    Verh Dtsch Ges Pathol; 2006; 90():210-5. PubMed ID: 17867599
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies.
    Xu-Monette ZY; Li J; Xia Y; Crossley B; Bremel RD; Miao Y; Xiao M; Snyder T; Manyam GC; Tan X; Zhang H; Visco C; Tzankov A; Dybkaer K; Bhagat G; Tam W; You H; Hsi ED; van Krieken JH; Huh J; Ponzoni M; Ferreri AJM; Møller MB; Piris MA; Winter JN; Medeiros JT; Xu B; Li Y; Kirsch I; Young KH
    J Immunother Cancer; 2019 Oct; 7(1):272. PubMed ID: 31640780
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma.
    Grønbaek K; Worm J; Ralfkiaer E; Ahrenkiel V; Hokland P; Guldberg P
    Blood; 2002 Aug; 100(4):1430-7. PubMed ID: 12149228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Somatic hypermutation targeting to intrinsic hotspots of immunoglobulin genes in follicular lymphoma and multiple myeloma.
    Belessi C; Stamatopoulos K; Stavroyianni N; Zoi K; Papadaki T; Kosmas C
    Leukemia; 2001 Nov; 15(11):1772-8. PubMed ID: 11681420
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantifying the role of aberrant somatic hypermutation in transformation of follicular lymphoma.
    Halldórsdóttir AM; Frühwirth M; Deutsch A; Aigelsreiter A; Beham-Schmid C; Agnarsson BA; Neumeister P; Richard Burack W
    Leuk Res; 2008 Jul; 32(7):1015-21. PubMed ID: 18180034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation.
    Weniger MA; Melzner I; Menz CK; Wegener S; Bucur AJ; Dorsch K; Mattfeldt T; Barth TF; Möller P
    Oncogene; 2006 Apr; 25(18):2679-84. PubMed ID: 16532038
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Model of Somatic Hypermutation Targeting in Mice Based on High-Throughput Ig Sequencing Data.
    Cui A; Di Niro R; Vander Heiden JA; Briggs AW; Adams K; Gilbert T; O'Connor KC; Vigneault F; Shlomchik MJ; Kleinstein SH
    J Immunol; 2016 Nov; 197(9):3566-3574. PubMed ID: 27707999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR.
    Pott C; Brüggemann M; Ritgen M; van der Velden VHJ; van Dongen JJM; Kneba M
    Methods Mol Biol; 2019; 1956():199-228. PubMed ID: 30779036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular analysis of immunoglobulin genes in primary intraocular lymphoma.
    Coupland SE; Hummel M; Müller HH; Stein H
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3507-14. PubMed ID: 16186327
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutational analysis of IgVH and BCL-6 genes suggests thymic B-cells origin of mediastinal (thymic) B-cell lymphoma.
    Csernus B; Timár B; Fülöp Z; Bognár A; Szepesi A; László T; Jáksó P; Warnke R; Kopper L; Matolcsy A
    Leuk Lymphoma; 2004 Oct; 45(10):2105-10. PubMed ID: 15370257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biased dA/dT somatic hypermutation as regulated by the heavy chain intronic iEmu enhancer and 3'Ealpha enhancers in human lymphoblastoid B cells.
    Komori A; Xu Z; Wu X; Zan H; Casali P
    Mol Immunol; 2006 Apr; 43(11):1817-26. PubMed ID: 16412510
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recurrent targets of aberrant somatic hypermutation in lymphoma.
    Khodabakhshi AH; Morin RD; Fejes AP; Mungall AJ; Mungall KL; Bolger-Munro M; Johnson NA; Connors JM; Gascoyne RD; Marra MA; Birol I; Jones SJ
    Oncotarget; 2012 Nov; 3(11):1308-19. PubMed ID: 23131835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders.
    Capello D; Deambrogi C; Rossi D; Lischetti T; Piranda D; Cerri M; Spina V; Rasi S; Gaidano G; Lunghi M
    Br J Haematol; 2008 May; 141(4):504-11. PubMed ID: 18318760
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations.
    Tamaru J; Hummel M; Marafioti T; Kalvelage B; Leoncini L; Minacci C; Tosi P; Wright D; Stein H
    Am J Pathol; 1995 Nov; 147(5):1398-407. PubMed ID: 7485402
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ongoing somatic hypermutation of the rearranged VH but not of the V-lambda gene in EBV-transformed rheumatoid factor-producing lymphoblastoid cell line.
    Chezar I; Lobel-Lavi L; Steinitz M; Laskov R
    Mol Immunol; 2008 Nov; 46(1):80-90. PubMed ID: 18718665
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary cutaneous marginal zone B-cell lymphomas are targeted by aberrant somatic hypermutation.
    Deutsch AJ; Frühwirth M; Aigelsreiter A; Cerroni L; Neumeister P
    J Invest Dermatol; 2009 Feb; 129(2):476-9. PubMed ID: 18704108
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary diffuse large B cell lymphoma of the stomach: analysis of somatic mutations in the rearranged immunoglobulin heavy chain variable genes indicates antigen selection.
    Driessen A; Tierens A; Ectors N; Stul M; Pittaluga S; Geboes K; Delabie J; De Wolf-Peeters C
    Leukemia; 1999 Jul; 13(7):1085-92. PubMed ID: 10400425
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line.
    Melzner I; Bucur AJ; Brüderlein S; Dorsch K; Hasel C; Barth TF; Leithäuser F; Möller P
    Blood; 2005 Mar; 105(6):2535-42. PubMed ID: 15572583
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Somatic mutations and intraclonal variations in the rearranged Vkappa genes of B-non-Hodgkin's lymphoma cell lines.
    Gabay C; Ben-Bassat H; Schlesinger M; Laskov R
    Eur J Haematol; 1999 Sep; 63(3):180-91. PubMed ID: 10485273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.